DeepNephro is a kidney-focused biotechnology company developing scalable human organoid platforms for disease modeling, drug safety evaluation, and therapeutic discovery.

Our mission is to close the gap between preclinical discovery and human clinical success in kidney disease by building high-fidelity, human-relevant kidney organoid platforms.